These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33368262)
1. Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3. Nascimento RP; Dos Santos BL; da Silva KC; Amaral da Silva VD; de Fátima Costa M; David JM; David JP; Moura-Neto V; Oliveira MDN; Ulrich H; de Faria Lopes GP; Costa SL J Cell Physiol; 2021 Jul; 236(7):5022-5035. PubMed ID: 33368262 [TBL] [Abstract][Full Text] [Related]
3. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment. Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646 [TBL] [Abstract][Full Text] [Related]
4. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion. Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948 [TBL] [Abstract][Full Text] [Related]
5. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling. Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424 [TBL] [Abstract][Full Text] [Related]
6. Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway. Ahmad N; Chen L; Yuan Z; Ma X; Yang X; Wang Y; Zhao Y; Jin H; Khaidamah N; Wang J; Lu J; Liu Z; Wu M; Wang Q; Qi Y; Wang C; Zhao Y; Piao Y; Huang R; Diao Y; Deng S; Shu X Neurotherapeutics; 2024 Sep; 21(5):e00431. PubMed ID: 39153914 [TBL] [Abstract][Full Text] [Related]
8. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all. Nowak B; Rogujski P; Janowski M; Lukomska B; Andrzejewska A Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188582. PubMed ID: 34144129 [TBL] [Abstract][Full Text] [Related]
11. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome. Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024 [TBL] [Abstract][Full Text] [Related]
12. IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling. Cui X; Jing X; Yi Q; Xiang Z; Tian J; Tan B; Zhu J Oncol Rep; 2019 Apr; 41(4):2148-2158. PubMed ID: 30816520 [TBL] [Abstract][Full Text] [Related]
13. STAT3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells. Chiang YC; Selvam P; Liu YX; Shih PC; Chen NF; Kuo HM; Lin HY; Wen ZH; Chen WF Environ Toxicol; 2024 Jun; 39(6):3292-3303. PubMed ID: 38415901 [TBL] [Abstract][Full Text] [Related]
14. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173 [TBL] [Abstract][Full Text] [Related]
15. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112 [TBL] [Abstract][Full Text] [Related]
16. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics. Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660 [TBL] [Abstract][Full Text] [Related]
17. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets. Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712 [TBL] [Abstract][Full Text] [Related]
18. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Gao H; Priebe W; Glod J; Banerjee D Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway. Szeliga M; Karpińska M; Rola R; Niewiadomy A Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121 [TBL] [Abstract][Full Text] [Related]
20. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms. Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]